FIORDOLIVA, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 809
EU - Europa 278
AS - Asia 110
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.233
Nazione #
US - Stati Uniti d'America 809
IT - Italia 78
UA - Ucraina 48
SE - Svezia 47
SG - Singapore 44
IE - Irlanda 41
CI - Costa d'Avorio 32
CN - Cina 32
DE - Germania 24
TR - Turchia 18
DK - Danimarca 13
FI - Finlandia 11
KR - Corea 9
GB - Regno Unito 7
IN - India 6
FR - Francia 5
MA - Marocco 3
BE - Belgio 2
EU - Europa 1
HK - Hong Kong 1
NL - Olanda 1
RU - Federazione Russa 1
Totale 1.233
Città #
Chandler 131
Fairfield 85
Ashburn 65
Jacksonville 63
Des Moines 52
Boardman 39
Dublin 37
Wilmington 36
Woodbridge 36
New York 34
Seattle 33
Abidjan 32
Houston 24
Singapore 22
Cambridge 18
Lawrence 16
Princeton 16
San Mateo 14
Turin 14
Redmond 11
San Diego 10
Ann Arbor 9
Centro 8
Beijing 7
Los Angeles 6
Pune 6
Ancona 5
Helsinki 5
Washington 5
Shanghai 4
Castelraimondo 3
Kilburn 3
Tolentino 3
Brussels 2
Civitanova Marche 2
Dallas 2
Guangzhou 2
Marche 2
Montegiorgio 2
Wuhan 2
Amsterdam 1
Bevagna 1
Chicago 1
Chiswick 1
Clifton 1
Falconara Marittima 1
Hangzhou 1
Harrison 1
Hong Kong 1
Hounslow 1
Jiaxing 1
London 1
Milan 1
Munich 1
Philadelphia 1
Phoenix 1
Qingdao 1
Saint Petersburg 1
San Severino Marche 1
Seoul 1
Stockholm 1
Tianjin 1
Wuxi 1
Xi'an 1
Totale 890
Nome #
The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases 112
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: a systematic review and meta-analysis 93
Questioning the prognostic role of BAP-1 immunohistochemistry in malignant pleural mesothelioma: A single center experience with systematic review and meta-analysis 87
Hyponatremia in cancer patients: Time for a new approach 85
Hyponatraemia is a predictor of clinical outcome for malignant pleural mesothelioma 85
Managing hyponatremia in lung cancer: latest evidence and clinical implications 85
Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma 82
Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients. 79
BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma 78
Risk of hyponatraemia in cancer patients treated with targeted therapies: A systematic review and meta-analysis of clinical trials 76
Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy 74
Screening of psychological distress in oncology and hematology department at Ospedali Riuniti Ancona 73
Developments in the management of advanced soft-tissue sarcoma –€“ Olaratumab in context 68
Syndrome of inappropriate antidiuresis in prostate adenocarcinoma with neuroendocrine differentiation: a case report and literature review 68
Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer 64
Weighing the prognostic role of hyponatremia in hospitalized patients with metastatic solid tumors: the HYPNOSIS study 63
Totale 1.272
Categoria #
all - tutte 7.240
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.240


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202066 0 0 0 0 10 0 9 0 12 2 11 22
2020/2021288 16 23 31 9 32 16 21 50 26 24 22 18
2021/2022136 10 20 5 2 15 13 3 10 10 17 10 21
2022/2023367 18 47 22 31 22 84 0 20 77 0 38 8
2023/2024187 23 4 12 11 26 59 4 13 0 6 1 28
2024/2025126 66 26 8 3 23 0 0 0 0 0 0 0
Totale 1.272